UBS Group’s Monarch Blue Chips Elite Index ETF MBCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.6K Buy
1,524
+1,512
+12,600% +$55K ﹤0.01% 7340
2025
Q4
$443 Sell
12
-117
-91% -$4.3K ﹤0.01% 9960
2025
Q3
$4.75K Buy
+129
New +$4.74K ﹤0.01% 8930
2025
Q1
Sell
-26
Closed -$896 10525
2024
Q4
$896 Buy
+26
New +$914 ﹤0.01% 9354
2024
Q1
Sell
-139
Closed -$4.03K 9747
2023
Q4
$4.03K Buy
+139
New +$3.78K ﹤0.01% 7914
2023
Q3
Sell
-623
Closed -$16.8K 9763
2023
Q2
$16.8K Buy
+623
New +$16K ﹤0.01% 6952
2023
Q1
Sell
-1,105
Closed -$26.2K 10036
2022
Q4
$26.2K Sell
1,105
-1,047
-49% -$24.2K ﹤0.01% 7377
2022
Q3
$46K Buy
2,152
+2,052
+2,052% +$48.6K ﹤0.01% 6428
2022
Q2
$2K Buy
+100
New +$2.38K ﹤0.01% 9582
2022
Q1
Sell
-196
Closed -$6K 10630
2021
Q4
$6K Buy
+196
New +$5.76K ﹤0.01% 9278
2021
Q2
Sell
-772
Closed -$19K 9628
2021
Q1
$19K Buy
+772
New +$19.2K ﹤0.01% 7437

Other funds holding MBCE

UBS Group's MBCE Position: Q1 2026 in Review

UBS Group increased its Monarch Blue Chips Elite Index ETF (MBCE) stake by 12,600% in Q1 2026, buying an estimated $55K and bringing the position to 1,524 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7340.

UBS Group first reported a position in MBCE in Q1 2021 and has held it in 11 quarters since. 11 funds tracked by Wall St. Rank hold MBCE as of Q1 2026.

  • UBS Group held 1,524 shares of Monarch Blue Chips Elite Index ETF worth $52.6K as of Q1 2026.
  • UBS Group bought 1,512 Monarch Blue Chips Elite Index ETF shares in Q1 2026, an estimated $55K.
  • Monarch Blue Chips Elite Index ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7340 holding.
  • UBS Group first reported a position in Monarch Blue Chips Elite Index ETF in Q1 2021 and has held it in 11 quarters since.
  • 11 funds tracked by Wall St. Rank held Monarch Blue Chips Elite Index ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.